# Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation

Study · id `cardio:ct-nct06721221` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06721221](<https://clinicaltrials.gov/study/NCT06721221>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06721221

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06721221. Allocation not applicable; no masking; primary purpose treatment. Start 2024-08-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06721221, source copy `cardio:ctgov-nct06721221-2024-12-11`, retrieved 2026-10-26)
- Started: 2024-08-01 (actual) (ClinicalTrials.gov record NCT06721221, source copy `cardio:ctgov-nct06721221-2024-12-11`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06721221, source copy `cardio:ctgov-nct06721221-2024-12-11`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06721221, source copy `cardio:ctgov-nct06721221-2024-12-11`, retrieved 2026-10-26)
- Countries: Hungary (ClinicalTrials.gov record NCT06721221, source copy `cardio:ctgov-nct06721221-2024-12-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06721221-2024-12-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation
- Acronym: SVtag
- Condition: Atrial Fibrillation (AF)
- Condition: Atrial Fibrillation Ablation
- Condition: Pulmonary Vein Isolation
- Intervention (Device): Point-by-point PVI with the QDot Micro catheter in QMODE+ setting with the Svtag software
- Lead sponsor: Semmelweis University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 0a4237eac7cfb0e55402cb8818d57b28f8e02723881fc6a9ddc1e633c7304e61
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
